[An increase in the median plasma values of progesterone in luteal deficiencies treated with clomifene citrate in the early follicular phase].
A clinical study performed during 265 cycles in 63 normo-ovulating and normo-menstruating patients, of whom 27 with a luteal phase defect (LPD), assessed by morphological, hormonal, echographic and clinic criteria. These were given Clomiphene Citrate, 100 mg per day from the second to sixth day of the cycle, for a total of 108 cycles. The other 36 patients, without any luteal abnormality, were utilized as a control group during 156 cycles. At the end of the study there were no significant differences in hormonal, echographic and morphological parameters between the two groups.
Scarpellini
L
L
II Istituto di Clinica Ostetrica e Ginecologica, Università degli Studi di Roma La Sapienza.
Scarpellini
F
F
Benvenuto
P
P
Manna
C
C
D002996:Clomiphene / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D005498:Follicular Phase / Q000187:drug effects*; D006801:Humans; D007247:Infertility, Female / Q000097:blood / Q000188:drug therapy*; D008183:Luteal Phase / Q000187:drug effects*; D011374:Progesterone / Q000097:blood*; D013997:Time Factors
D002996:Clomiphene; D011374:Progesterone
Incremento dei valori plasmatici medi di progesterone nei difetti luteali trattati con citrato di clomifene in fase follicolare precoce.